Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹677.64 Cr
Profit after tax
₹-57.88 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations677.64−4.29%2,931.90
Other income18.16−26.63%55.94
Total income695.80−5.05%2,987.84
Employee benefit expense389.10+10.57%1,446.93
Finance costs37.09−13.26%174.18
Depreciation & amortisation90.68+11.47%338.69
Total expenses745.33+7.79%2,879.14
Profit before tax-51.22−232.45%104.90
Tax expense6.66−56.36%7.45
Profit after tax-57.88−347.24%97.45
Total comprehensive income-38.62−110.97%845.37
Earnings per share
Earnings per share, basic₹-3.69₹6.22
Earnings per share, diluted₹-3.69₹6.22

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Dishman Carbogen Amcis reported Q4 FY26 revenue of INR 851 crores, up close to 19% year-on-year, with EBITDA margin at 19.1% for the quarter. For the full year, revenue rose to INR 2,932 crores from INR 2,711 crores, and EBITDA margin improved to 19.3% from 17.3% in FY25. Management discussed a proposed related-party external commercial borrowing to refinance high-cost India debt, growth in the Vitamin D analogs and ADC linker-payload businesses, and plans for India capacity ramp-up.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 36 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 21 Aug 2026.